$MAZE insider trading

Over the last 12 months, Maze Therapeutics insiders reported no purchases and 12 sales totaling $4.4M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.

$4.4M
12
3
100%
Side
$10K$100K$1.0M$10MMay '26JunJulAug
Coloma Jason V
Dandekar Atul
Bernstein Harold

All insider trades

Aug 3, 2026Coloma Jason V▼ Sale34,501$26.73$922K-11.9%
Jul 29, 2026Dandekar Atul▼ Sale7,500$27.34$205K-22.2%
Jul 1, 2026Bernstein Harold▼ Sale14,609$29.9$437K-100%
Jul 1, 2026Coloma Jason V▼ Sale34,501$29.98$1.0M-10.7%
Jun 29, 2026Dandekar Atul▼ Sale7,500$28.02$210K-22.2%
Jun 23, 2026Coloma Jason V▼ Sale27,858$26.04$725K-8%
Jun 1, 2026Coloma Jason V▼ Sale553$26.24$15K-1.9%
Jun 1, 2026Coloma Jason V▼ Sale6,090$26.2$160K-1.7%
Jun 1, 2026Bernstein Harold▼ Sale1,600$26.36$42K-100%
Jun 1, 2026Bernstein Harold▼ Sale13,253$25.57$339K-89.2%
May 29, 2026Dandekar Atul▼ Sale7,500$26.34$198K-23.2%
May 22, 2026Coloma Jason V▼ Sale4,504$26$117K-1.2%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MAZE feed.

MAZE Insider Trading — Form 4 Buys & Sells | alphai